Two Sigma Investments’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
Two Sigma Investments's CCCC Position: Q3 2026 in Review
Two Sigma Investments increased its C4 Therapeutics (CCCC) stake by 8% in Q3 2026, buying an estimated $1.03M and bringing the position to 3,746,738 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #1362.
Two Sigma Investments first reported a position in CCCC in Q2 2021 and has held it in 20 quarters since. The position peaked at $16.2M in Q2 2026. 123 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.
- Two Sigma Investments held 3,746,738 shares of C4 Therapeutics worth $12.5M as of Q3 2026.
- Two Sigma Investments bought 277,031 C4 Therapeutics shares in Q3 2026, an estimated $1.03M.
- C4 Therapeutics made up 0.01% of Two Sigma Investments's portfolio in Q3 2026, its #1362 holding.
- Two Sigma Investments first reported a position in C4 Therapeutics in Q2 2021 and has held it in 20 quarters since.
- Two Sigma Investments's C4 Therapeutics position peaked at $16.2M in Q2 2026.
- 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.